Anti-C1q autoantibodies in lupus nephritis: Prevalence and clinical significance

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 193-200

  Sinico, Renato Alberto ^a   Radice, Antonella ^a   Ikehata, Masami ^a   Giammarresi, Gaia ^b   Corace, Caterina ^a   Arrigo, Girolamo ^a   Bollini, Bruna ^a   Li Vecchi, Maurizio ^b  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Anti C1q antibodies; Anti DNA antibodies; Autoimmune disease; Glomerulonephritis; Lupus nephritis; Renal flares; SLE; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIBODY TITER; BLOOD DONOR; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PREVALENCE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 23744457094     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.020     Document Type: Conference Paper

References (22)

1. AGNELLO, V., D. KOFFLER, J.W. EISENBERG et al. 1971. C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J. Exp. Med. 134(suppl.): 228S-241S.
2. UWATOKO, S. & M. MANNIK. 1988. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J. Clin. Invest. 82: 816-824.
3. SIEGERT C.E., M.R. DAHA, C. HALMA, et al. 1992. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 10: 19-23.
4. SEELEN, M.A., L.A. TROUW & M.R. DAHA. 2003. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr. Opin. Nephrol. Hypertens. 12: 619-624.
5. WISNIESKI, J.J. & S.M. JONES. 1992. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J. Immunol. 148: 1396-1403.
6. MORONI, G., M. TRENDELENBURG, N. DEL PAPA, et al. 2001. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am. J. Kidney Dis. 37: 490-498.
7. TRENDELENBURG, M., J. MARFURT, I. GERBER, et al. 1999. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum. 42: 187-188.
8. HORVATH, L., L. CZIRJAK, B. FEKETE, et al. 2001. High levels of antibodies against C1q are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin. Exp. Rheumatol. 19: 667-672.
9. SIEGERT, C.E., M.R. DAHA, C.M. TSENG, et al. 1993. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann. Rheum. Dis. 52: 851-856.
10. COREMANS, I.E., P.E. SPRONK, H. BOOTSMA, et al. 1995. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26: 595-601.
11. SINICO, R.A., B. BOLLINI, E. SABADINI, et al. 2002. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J. Nephrol. Suppl. 6: S20-S27.
12. TAN, E.M., A.S. COHEN, J.F. FRIES, et al. 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
13. VITALI, C., W. BENCIVELLI, D.A. ISENBERG, et al. 1992. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol. 10: 541-547.
14. SIEGERT, C.E., M.R. DAHA, E.A. VAN DER VOORT & F.C. BREEDVELD. 1990. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum. 33: 1646-1654.
15. OELZNER, P., B. DELIYSKA, R. FUNFSTUCK, et al. 2003. Anti-C1q antibodies and anti-endothelial cell antibodies in systemic lupus erythematosus- relationship with disease activity and renal involvement. Clin. Rheumatol. 22: 271-278.
16. MARTO, N., M.L. BERTOLACCINI, E. CALABUIG, et al. 2005. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 64: 444-448.
17. SIEGERT, C., M. DAHA, M.L. WESTEDT, et al. 1991. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18: 230-234.
18. FREMEAUX-BACCHI, V., L.H. NOEL & J.A. SCHIFFERLI. 2002. No lupus nephritis in the absence of antiC1q autoantibodies? Nephrol. Dial. Transplant. 17: 2041-2043.
19. MANNIK, M. & M.H. WENER. 1997. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 40: 1504-1511.
20. MANNIK, M., C.E. MERRILL, L.D. STAMPS & M.H. WENER. 2003. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J. Rheumatol. 30: 1495-1504.
21. TROUW, L.A., T.W. GROENEVELD, M.A. SEELEN, et al. 2004. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114: 679-688.
22. HOLERS, V.M., 2004. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J. Clin. Invest. 114: 616-619.